Infective dermatitis
ICD-10 L30.3 is a billable code used to indicate a diagnosis of infective dermatitis.
Infective dermatitis, classified under ICD-10 code L30.3, refers to a skin condition characterized by inflammation and infection of the skin, often resulting from bacterial, viral, or fungal pathogens. Clinically, patients may present with erythema, swelling, vesicles, pustules, and crusting lesions, which can occur on various body parts, including the face, extremities, and trunk. The anatomy involved primarily includes the epidermis and dermis, where the inflammatory response is triggered by the invading microorganisms. Disease progression can vary; mild cases may resolve spontaneously, while severe infections can lead to complications such as cellulitis or systemic infection. Diagnostic considerations include a thorough clinical examination, history taking, and, when necessary, laboratory tests such as cultures or skin scrapings to identify the causative agent. Accurate diagnosis is crucial for effective treatment, which may involve topical or systemic antibiotics, antifungals, or antivirals depending on the underlying cause.
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
L30.3 encompasses various infective dermatitis conditions, including impetigo, folliculitis, and dermatitis due to viral infections such as herpes simplex. Diagnostic criteria typically involve clinical signs of infection and may require laboratory confirmation.
L30.3 should be used when there is clear evidence of an infectious etiology in dermatitis. If the dermatitis is primarily allergic or irritant in nature, other codes such as L30.0 or L30.1 should be considered.
Documentation for L30.3 should include a detailed clinical assessment, description of the lesions, any laboratory findings, and the treatment plan. Evidence of the infectious agent, if identified, is critical for accurate coding.
